These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
264 related articles for article (PubMed ID: 33893295)
21. Repositioning of histamine H Ge S; Wang X; Hou Y; Lv Y; Wang C; He H Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607 [TBL] [Abstract][Full Text] [Related]
22. Potential Roles of the Renin-Angiotensin System in the Pathogenesis and Treatment of COVID-19. Lu L; Liu X; Jin R; Guan R; Lin R; Qu Z Biomed Res Int; 2020; 2020():7520746. PubMed ID: 33204713 [TBL] [Abstract][Full Text] [Related]
23. "Molecular Masks" for ACE2 to Effectively and Safely Block SARS-CoV-2 Virus Entry. Shukla SP; Cho KB; Rustagi V; Gao X; Fu X; Zhang SX; Guo B; Udugamasooriya DG Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445669 [TBL] [Abstract][Full Text] [Related]
24. Effects of SARS-CoV-2 on Cardiovascular System: The Dual Role of Angiotensin-Converting Enzyme 2 (ACE2) as the Virus Receptor and Homeostasis Regulator-Review. Aleksova A; Gagno G; Sinagra G; Beltrami AP; Janjusevic M; Ippolito G; Zumla A; Fluca AL; Ferro F Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33926110 [TBL] [Abstract][Full Text] [Related]
25. RAAS Blockade and COVID-19: Mechanistic Modeling of Mas and AT1 Receptor Occupancy as Indicators of Pro-Inflammatory and Anti-Inflammatory Balance. Melissa Hallow K; Dave I Clin Pharmacol Ther; 2021 Apr; 109(4):1092-1103. PubMed ID: 33506503 [TBL] [Abstract][Full Text] [Related]
26. Free SARS-CoV-2 Spike Protein S1 Particles May Play a Role in the Pathogenesis of COVID-19 Infection. Letarov AV; Babenko VV; Kulikov EE Biochemistry (Mosc); 2021 Mar; 86(3):257-261. PubMed ID: 33838638 [TBL] [Abstract][Full Text] [Related]
27. COVID-19, hypertension, and RAAS blockers: the BRACE-CORONA trial. Mancia G Cardiovasc Res; 2020 Dec; 116(14):e198-e199. PubMed ID: 33245754 [No Abstract] [Full Text] [Related]
28. Coronavirus Disease 2019 and Hypertension: The Role of Angiotensin-Converting Enzyme 2 and the Renin-Angiotensin System. Edmonston DL; South AM; Sparks MA; Cohen JB Adv Chronic Kidney Dis; 2020 Sep; 27(5):404-411. PubMed ID: 33308506 [TBL] [Abstract][Full Text] [Related]
29. Angiotensin-converting-enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blocker (ARB) use in COVID-19 prevention or treatment: A paradox. Javanmard SH; Heshmat-Ghahdarijani K; Vaseghi G Infect Control Hosp Epidemiol; 2021 Jan; 42(1):118-119. PubMed ID: 32362297 [No Abstract] [Full Text] [Related]
30. Experimental data using candesartan and captopril indicate no double-edged sword effect in COVID-19. Pedrosa MA; Valenzuela R; Garrido-Gil P; Labandeira CM; Navarro G; Franco R; Labandeira-Garcia JL; Rodriguez-Perez AI Clin Sci (Lond); 2021 Feb; 135(3):465-481. PubMed ID: 33479758 [TBL] [Abstract][Full Text] [Related]
32. The Role of the Renin-Angiotensin System in Severe Acute Respiratory Syndrome-CoV-2 Infection. Alfano G; Guaraldi G; Fontana F; Ferrari A; Magistroni R; Mussini C; Cappelli G; Blood Purif; 2021; 50(2):263-267. PubMed ID: 32344395 [No Abstract] [Full Text] [Related]
33. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial. Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734 [TBL] [Abstract][Full Text] [Related]
34. Molecular pathways triggered by COVID-19 in different organs: ACE2 receptor-expressing cells under attack? A review. Saba L; Gerosa C; Fanni D; Marongiu F; La Nasa G; Caocci G; Barcellona D; Balestrieri A; Coghe F; Orru G; Coni P; Piras M; Ledda F; Suri JS; Ronchi A; D'Andrea F; Cau R; Castagnola M; Faa G Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12609-12622. PubMed ID: 33336781 [TBL] [Abstract][Full Text] [Related]
35. Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity. Gonçalves J; Santos CD; Fresco P; Fernandez-Llimos F Rev Port Cardiol; 2023 Apr; 42(4):373-383. PubMed ID: 36893838 [TBL] [Abstract][Full Text] [Related]
36. SARS-CoV-2 Spike Protein Destabilizes Microvascular Homeostasis. Panigrahi S; Goswami T; Ferrari B; Antonelli CJ; Bazdar DA; Gilmore H; Freeman ML; Lederman MM; Sieg SF Microbiol Spectr; 2021 Dec; 9(3):e0073521. PubMed ID: 34935423 [TBL] [Abstract][Full Text] [Related]
37. ACE2: from protection of liver disease to propagation of COVID-19. Warner FJ; Rajapaksha H; Shackel N; Herath CB Clin Sci (Lond); 2020 Dec; 134(23):3137-3158. PubMed ID: 33284956 [TBL] [Abstract][Full Text] [Related]
38. SARS-CoV-2 and hypertension. Ravichandran B; Grimm D; Krüger M; Kopp S; Infanger M; Wehland M Physiol Rep; 2021 Jun; 9(11):e14800. PubMed ID: 34121359 [TBL] [Abstract][Full Text] [Related]
39. Possible inhibition of GM-CSF production by SARS-CoV-2 spike-based vaccines. Li J; Wang P; Tracey KJ; Wang H Mol Med; 2021 May; 27(1):49. PubMed ID: 34022793 [TBL] [Abstract][Full Text] [Related]
40. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial. Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]